QS Investors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

QS Investors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,475	Closed	-$263K	–	1666
2019 Q3	$263K	Buy	3,475 +1,100	+46%	+$89.3K	﹤0.01%	1135
2019 Q2	$203K	Buy	2,375 +400	+20%	+$39.6K	﹤0.01%	1217
2019 Q1	$214K	Buy	1,975 +975	+98%	+$97.1K	﹤0.01%	1201
2018 Q4	$85K	Hold	1,000	–	–	﹤0.01%	1365
2018 Q3	$98K	Hold	1,000	–	–	﹤0.01%	1395
2018 Q2	$116K	Buy	+1,000	New	+$110K	﹤0.01%	1375
2017 Q4	–	Sell	-2,300	Closed	-$259K	–	2020
2017 Q3	$259K	Buy	2,300 +700	+44%	+$76.2K	﹤0.01%	1132
2017 Q2	$179K	Hold	1,600	–	–	﹤0.01%	1252
2017 Q1	$187K	Hold	1,600	–	–	﹤0.01%	1254
2016 Q4	$168K	Buy	1,600 +1,200	+300%	+$126K	﹤0.01%	1145
2016 Q3	$44K	Sell	400 -1,200	-75%	-$159K	﹤0.01%	1361
2016 Q2	$233K	Buy	+1,600	New	+$227K	﹤0.01%	1071
2016 Q1	–	Sell	-1,177	Closed	-$182K	–	2081
2015 Q4	$182K	Buy	+1,177	New	+$172K	﹤0.01%	1110

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

QS Investors's TARO Position: Q4 2019 in Review

QS Investors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2019, closing a stake of 3,475 shares — an estimated $263K sold.

QS Investors first reported a position in TARO in Q4 2015 and held it in 13 quarters. The position peaked at $263K in Q3 2019. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2019.

QS Investors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2019 after selling out during the quarter.
QS Investors sold 3,475 Taro Pharmaceutical Industries Ltd. shares in Q4 2019, an estimated $263K.
QS Investors first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 13 quarters.
QS Investors's Taro Pharmaceutical Industries Ltd. position peaked at $263K in Q3 2019.
94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2019.

Based on QS Investors's 13F filing for Q4 2019, filed 14 Feb 2020.